Disease/Infection News

RSS

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

6 Aug 2012

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

A significant discovery in the development of next-generation antibiotics has been made by Scottish biotechnology company Aquapharm.

6 Aug 2012

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).

6 Aug 2012

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

Luminex Corporation announced today that Public Health Wales is using Luminex's CE marked xTAG Gastrointestinal Pathogen Panel (GPP) for outbreak investigation activities during Olympic and Paralympic training and events taking place in Wales. Results of a substantial diagnostic validation of the GPP test conducted by The Public Health Wales Microbiology laboratory team at the University Hospital of Wales, Cardiff, are anticipated to be published in a peer reviewed journal

From Luminex 6 Aug 2012

Drug molecules designed for influenza may be adapted to treat other viruses

St. Jude Children's Research Hospital study shows how compounds blocking an enzyme universal to all influenza viruses may allow development of new antiviral drugs that also avoid the problem of drug resistance

3 Aug 2012

Science magazine recaps issues discussed at AIDS 2012

Science looks back at the XIX International AIDS Conference (AIDS 2012), which ended last week in Washington, D.C., writing, "The battle against HIV is having more success than ever. ... But several presentations made clear that a gulf separates aspirations from reality when it comes to 'ending AIDS,' which [Secretary of State Hillary] Clinton and many other prominent speakers at the conference emphasized was now possible."

3 Aug 2012

Panel discussion looks back on AIDS 2012, explores possible topics for AIDS 2014

Devex reports on a panel discussion held in Washington, D.C. Wednesday during which experts "looked back at the main surprises of the just-concluded [XIX International AIDS Conference (AIDS 2012)], and offered predictions on what the 2014 follow-up [in Melbourne, Australia] will focus on."

3 Aug 2012

Study investigates standard practices for insertion and management of urinary catheters

A major international study led by University of Adelaide researchers aims to prevent death and serious illness caused by one of the most common infections contracted by patients in hospitals.

3 Aug 2012

Investment in health systems 'a critical prerequisite' in beginning to end AIDS

The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., "ignited momentum to shift from 'fighting AIDS' to 'ending AIDS,'" Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece.

3 Aug 2012

Mylan licenses rights to produce and market generic versions of Gilead HIV/AIDS therapies

Mylan Inc. today announced the establishment of a new agreement between its subsidiary Mylan Laboratories Limited and Gilead Sciences Inc. Under this agreement, Mylan has licensed the rights to produce and market generic versions of Gilead HIV/AIDS therapies containing Emtricitabine, including single and fixed-dose combinations.

3 Aug 2012

Financial Times publishes special report focusing on global health policy issues

The Financial Times on Wednesday published a special report on global health policy to coincide with the Global Health Policy Summit in London.

3 Aug 2012

Clinton tours health center in Senegal's capital on first stop of 10-day Africa trip

On the first stop of a 10-day tour of Africa, Secretary of State Hillary Clinton stopped at the Phillipe Maguilen Senghor Health Center in Dakar, Senegal, where Awa Marie Coll-Seck, the country's Minister of Health, "explained to Secretary Clinton how these operational centers dramatically improve maternal and child health," according to a post in USAID's "IMPACTblog."

3 Aug 2012

Partners in health reports on efforts to curb Haiti's cholera epidemic using oral vaccinations

"In April, Partners In Health [PIH] responded to Haiti's cholera epidemic by providing oral vaccinations to 45,000 people living in the country's Artibonite region -- specifically, to two rice-farming communities hit hard by cholera," Louise Ivers, senior health and policy adviser at PIH, reports in an article on the organization's webpage.

3 Aug 2012

Rodent study shows potential for development of more virulent malaria if 'leaky' vaccine used

Using a rodent model to examine the long-term effects of a potential malaria vaccine, a new study published in PLoS Biology by researchers at Penn State University shows that the vaccine could lead to the development of more virulent forms of malaria, the PLoS blog "Biologue" reports.

3 Aug 2012

Change in drug policy needed to reverse HIV/AIDS epidemic in Eastern Europe, Central Asia

Noting the United Nations last week announced the appointment of Dr. Michel Kazatchkine, the former head of the Global Fund to Fight AIDS, Tuberculosis and Malaria, as the U.N. Secretary-General's new special envoy for HIV/AIDS in Eastern Europe and Central Asia," Kasia Malinowska-Sempruch, director of the Open Society Foundations' global drug policy program, writes in this Huffington Post opinion piece.

3 Aug 2012

PEPFAR announces $60M initiative to support implementation of science research, evaluation programs

PEPFAR on Wednesday "announced awards for a $60 million initiative, with potential for additional funding in year three, to support implementation science research and the evaluation of programs established under PEPFAR," according to a U.S. State Department media note.

3 Aug 2012

Australian scientists discover new virus in bats

Australian scientists have discovered a new virus in bats that could help shed light on how Hendra and Nipah viruses cause disease and death in animals and humans. The new virus - named 'Cedar' after the Queensland location where it was discovered - is a close relative of the deadly Hendra and Nipah viruses.

3 Aug 2012

Access to dental care alone is not sufficient to meet oral health needs of adults with I/DD

A comprehensive study using electronic dental records to profile the oral health status of adults with intellectual and developmental disabilities (I/DD) has concluded that access to specialized dental care alone is not sufficient to meet the community's substantial oral health needs.

2 Aug 2012

Changing behavior in Haiti to prevent cholera poses challenges

Noting that several organizations recently have closed or consolidated their cholera treatment centers in Haiti, Jason Hayes with the Pulitzer Center on Crisis Reporting writes in an opinion analysis in the Huffington Post Blog, "In order to stop cholera, a water-borne illness, you need to change the ways people interact with water. It is no easy task."

2 Aug 2012

U.S. bipartisanship fundamental to continued progress against HIV/AIDS

"Health care, taxes, energy, favorite flavor of ice cream -- it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted at the XIX International AIDS Conference (AIDS 2012) in our nation's capital last week: the fight against HIV/AIDS," former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in "The Week."

2 Aug 2012

Disease/Infection News

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

Drug molecules designed for influenza may be adapted to treat other viruses

Science magazine recaps issues discussed at AIDS 2012

Panel discussion looks back on AIDS 2012, explores possible topics for AIDS 2014

Study investigates standard practices for insertion and management of urinary catheters

Investment in health systems 'a critical prerequisite' in beginning to end AIDS

Mylan licenses rights to produce and market generic versions of Gilead HIV/AIDS therapies

Financial Times publishes special report focusing on global health policy issues

Clinton tours health center in Senegal's capital on first stop of 10-day Africa trip

Partners in health reports on efforts to curb Haiti's cholera epidemic using oral vaccinations

Rodent study shows potential for development of more virulent malaria if 'leaky' vaccine used

Change in drug policy needed to reverse HIV/AIDS epidemic in Eastern Europe, Central Asia

PEPFAR announces $60M initiative to support implementation of science research, evaluation programs

Australian scientists discover new virus in bats

Access to dental care alone is not sufficient to meet oral health needs of adults with I/DD

Changing behavior in Haiti to prevent cholera poses challenges

U.S. bipartisanship fundamental to continued progress against HIV/AIDS

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News